Benzodiazepine's utilization in continental Portugal (1999-2003);Utilização de benzodiazepinas em Portugal continental (1999-2003)

Acta Medica Portuguesa

Volumn 19, Issue 3, 2006, Pages 239-246

  Furtado, Cláudia ^a   Teixeira, Inês ^a  

^a Inst Nac Farmacia Medicamento   (Portugal)

Author keywords

Benzodiazepines; Drug utilization; Pharmacoepidemiology

Indexed keywords

ALPRAZOLAM; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; BROMAZEPAM; BROTIZOLAM; CETAZOLAM; CHLORDIAZEPOXIDE; CLOBAZAM; CLORAZEPATE; CLOXAZOLAM; DIAZEPAM; ESTAZOLAM; ETHYL LOFLAZEPATE; FLUNITRAZEPAM; FLURAZEPAM; HALAZEPAM; HYPNOTIC AGENT; LOPRAZOLAM; LORAZEPAM; LORMETAZEPAM; MEDAZEPAM; MEXAZOLAM; MIDAZOLAM; NORDAZEPAM; OXAZEPAM; PRAZEPAM; QUAZEPAM; TEMAZEPAM; TRIAZOLAM; UNCLASSIFIED DRUG; ZOLPIDEM;

AMBULATORY CARE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG MARKETING; DRUG RESEARCH; DRUG UTILIZATION; HEALTH SERVICE; HUMAN; PORTUGAL; PRESCRIPTION;

BENZODIAZEPINES; CROSS-SECTIONAL STUDIES; DRUG UTILIZATION; HUMANS; PORTUGAL; RETROSPECTIVE STUDIES;

EID: 33750210777     PISSN: None     EISSN: 16460758     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. LANCE P, BRIAN J: Addiction: Part I. Benzodiazepines-Side Effects, Abuse Risk and Alternatives. Am Fam Physician 2000; 61(7):2121-8
2. TONKS A: Clinical Review - Treating Generalised Anxiety Disorder. Br Med J 2003; 326: 700-702
3. GARRET J, OSSWALD W (Coord.): Terapêutica Medicamentosa e suas bases farmacológicas: manual de farmacologia e farmacoterapia. Porto Editora
4. VAN HULTEN R, BAKKER AB, LODDER AC, TEEUW KB, BAKKER A, LEUFKENS HG: The impact of attitudes and beliefs on length of benzodiazepine use: a study among inexperienced and experienced benzodiazepine users. Social Science & Medicine 2003;56(6):1345-54.
5. FRENCH DD, CAMPBELL R, SPEHAR A, ANGARAN DM: Benzodiazepines and injury: a risk adjusted model. Pharmacoepidemiology and Drug Safety 2005; 14(1):17-24
6. MARIA V, PIMPÃO MV, CARVALHO ML: Caracterização do Consumo de Benzodiazepinas em Cuidados de Saúde Primários. Revista Portuguesa de Clínica Geral 1994; 11:99-114
7. BENDTSEN P, HENSING G, MCKENZIE L, STRIDSMAN AK: Prescribing benzodiazepines- a critical incident study of a physician dilemma. Social Science & Medicine 1999; 49(4):459-67
8. MAGRINI N, VACCHERI A, PARMA E et al: Use of benzodiazepines in the Italian general population: prevalence, pattern of use and risk factors for use. Eur J Clin Pharmacol 1996;50(1-2):19-25
9. DE LAS CUEVAS C, SANZ E, DE LA FUENTE JA, CABRERA C, MATEOS A: Prescribed daily doses and 'risk factors' associated with the use of benzodiazepines in primary care. Pharmacoepidemiol and Drug Safety 1999;8(3):207-16
10. ISACSON D, BINGEFORS K, WENNBERG M, DAHLSTROM M: Factors associated with high-quantity prescriptions of benzodiazepines in Sweden. Social Science and Medicine 1993;36(3):343-51.
11. DE LAS CUEVAS C, SANZ EJ: Controversial issues associated with the prescription of benzodiazepines by general practitioners and psychiatrists. Medical Science Monitor 2004; 10(7): 288-293
12. GARCIA DEL POZO J, DE ABAJO IGLESIAS FJ, CARVAJAL GARCIA-PANDO A, MONTERO COROMINAS D, MADURGA SANZ M, GARCIA DEL POZO V: The use of anxiolytic and hypnotic drugs in Spain (1995-2002). Revista Española Salud Publica 2004; 78(3):379-87
13. ANTÓNIO A, REMÍSIO E: Evolução do consumo de benzodiazepinas em Portugal de 1995 a 2001. Observatório do Medicamento e dos Produtos de Saúde INFARMED 2002.
14. CARMONA R, BICHO C: Serão as benzodiazepinas a panaceia para todos os males dos Portugueses? Boletim de Farmacovigilância INFARMED 2001; 5 (1):2-3
15. Medicines Consumption in the Nordic Countries 1999-2003. Disponível em http://www.nom-nos.dk/Medicinebook/ medicines%20consumption.pdf (acedido em Junho de 2005)
16. International Narcotic Control Board: Report of the INCB for 2004. Disponivel em http://www.incb.org/e/ind_ar.htm
17. World Health Organization Collaborating Centre for Drug Statistics Methodology: Anatomical Therapeutic Chemical (ATC) classification index including defined daily doses (DDD) for plain substances. Disponível em http://www.whocc.no/atcddd/ (acedido em Janeiro 2005)
18. Euro Med Stat: The Library of European Union Pharmaceutical Indicators. Disponivel em http://www.euromedstat.cnr.it (acedido em Junho 2005)
19. Instituto Nacional de Estatística: Disponível em www.ine.pt (acedido em Junho 2005)
20. ALVES E: Importância Económica do Mercado do Medicamento. O Medicamento na Estratégia de Saúde: da Qualidade à Eficiência. 2as Jornadas do INFARMED. Lisboa: INFARMED 1998; 83-95.